Psychedelic research continues to push the boundaries of scientific exploration, unveiling new frontiers and challenging preconceived notions. From cutting-edge studies on therapeutic applications to mind-expanding investigations into consciousness, let's embark on a journey through the expanding universe of psychedelic research.

Enthea, a provider of psychedelic healthcare insurance plans, declared that it will expand its services into 40 markets across the US in 2023 with the goal of making workplace benefits for psychedelic-assisted therapies reasonable, equitable, and available.

New Jersey Introduced a bill that would legalize the possession, home cultivation, ingesting, and gifting of psilocybin mushrooms for adults 21 and older to promote mental health and wellness

B.C.-based company, Optimi Health has harvested its first cultivation of psilocybin mushrooms at its Health Canada-licensed facilities in Princeton, B.C., positioning itself as a major player in the burgeoning psychedelic sector. According to Optimi's head cultivator, Todd Henderson, The $14-million venture consists of two 10,000-square-feet facilities with a combined total of 10 growing rooms that can produce approximately 2,000 kilograms of dried psilocybin mushrooms a month.

Activists staged a demonstration outside of the Drug Enforcement Administration headquarters in Virginia, demanding that the agency allow terminally ill patients to access psilocybin therapy. The Protest was meant to call attention to DEA’s obstruction of Right to Try statutes at the federal and state level that patients and advocates say should facilitate legal use of psychedelics.

Silo Wellness has recently gone public on the Canadian Securities Exchange. After launching a psilocybin nasal spray for Micro-Dosing, and psychedelic retreat centers in Jamaica and Oregon, Silo is currently only trading at 0.24 Cents per share!

UNLV neuroscientist Dustin Hines and wife Rochelle Hines are uncovering how psychedelics affect brain activity at the Hines Lab at the UNLV campus.

PharmaTher is a specialty life science company focused on the research and development of psychedelics. They have recently filed patents with the FDA to mix FDA approved neurological drugs with Ketamine, Psilocybin, Cannabis, and MDMA to treat neurological disorders using GelMA micro-needle technology and transdermal patches.

Minerco Magic Mushroom Company Releases SHRU Cryptocurrency and is about to press 1 million psilocybin micro-tablets!

The decriminalization of entheogenic plants in Ann Arbor has sparked a movement in Michigan, as the new Washtenaw County prosecutor Eli Savit, decides to stop prosecuting individuals that are in possession of psychedelic plants and fungi.

Today we thank the United States Veterans for their service but, do we as a nation, make sure they are getting the proper treatment required to combat PTSD on American Soil?

FDA is helping to speed up the process of researching and approving psilocybin, MDMA, and Ketamine for breakthrough treatments in patients with Depression, Anxiety, PTSD, and even addiction.